Combined Therapeutics Revenue and Competitors
Estimated Revenue & Valuation
- Combined Therapeutics's estimated annual revenue is currently $2.6M per year.
- Combined Therapeutics's estimated revenue per employee is $155,000
Employee Data
- Combined Therapeutics has 17 Employees.
- Combined Therapeutics grew their employee count by 6% last year.
Combined Therapeutics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | President and co-founder CEO | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Managing Director France | Reveal Email/Phone |
4 | Lab Manager | Reveal Email/Phone |
5 | Research Associate, Biology | Reveal Email/Phone |
6 | Associate Scientist | Reveal Email/Phone |
Combined Therapeutics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 2 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 6 | 0% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | $5.4M | 35 | 3% | N/A | N/A |
#10 | $1.6M | 10 | 0% | N/A | N/A |
What Is Combined Therapeutics?
CTx is an early stage startup developing the second generation of therapeutic & intelligent mRNA. Thanks to its delivery and modulation platform, CTx is killing cancer cells and is sparing healthy cells. CTx is located in Cambridge (USA) and London (UK).
keywords:N/A
N/A
Total Funding
17
Number of Employees
$2.6M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $8.5M | 17 | -78% | $305.9M |
#2 | $3.5M | 17 | -6% | N/A |
#3 | $1.5M | 17 | N/A | N/A |
#4 | $1.5M | 17 | 6% | N/A |
#5 | $2.6M | 17 | 0% | N/A |